Previous studies have linked up-regulation of Brm and BRG1 to metastatic ability of various cancers including pancreatic cancer, breast cancer, and melanoma (Numata et al. 2013; Bai et al. 2013; Saladi et al. 2010). Here, SMARCA2 is linked to familial pancreatic carcinoma.